Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus

Documenti analoghi

• Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren’s syndrome
  di: Toker, E, et al.
  Pubblicazione: (2004)
• Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome
  di: Mofors, J., et al.
  Pubblicazione: (2019)
• Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero
  di: Hedlund, Malin, et al.
  Pubblicazione: (2020)
• Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study
  di: Tzioufas, A, et al.
  Pubblicazione: (2002)
• Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren’s syndrome
  di: Zuo, Jian, et al.
  Pubblicazione: (2016)